Clinical trial
Safety & Efficacy of Oral Mucosal Carbon Dioxide Pressure (POMCO2) Measurement to Monitor Tissue Perfusion
NCT05499624 is registered in ClinicalTrials.gov with ExoStat Medical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety & Efficacy of Oral Mucosal Carbon Dioxide Pressure (POMCO2) Measurement to Monitor Tissue Perfusion
- Lead sponsor
- ExoStat Medical, Inc.
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- November 22, 2022
- Completion date
- January 9, 2023
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypoperfusion